Fellowship · St. Louis, MO
Sponsored by SSM Health/Saint Louis University School of Medicine
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.
The New England journal of medicine · 2023 · 376 citations · Manige Konig
Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016-2022) from the T1D Exchange Quality Improvement Collaborative.
Diabetes technology & therapeutics · 2023 · 177 citations · Alexis McKee
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study.
Lancet (London, England) · 2023 · 151 citations · Manige Konig
Association of Circulating Sex Hormones With Inflammation and Disease Severity in Patients With COVID-19.
JAMA network open · 2021 · 124 citations · Sandeep Dhindsa
Perioperative Care of Patients Using Wearable Diabetes Devices.
Anesthesia and analgesia · 2025 · 16 citations · Alexis McKee
Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review.
Diabetes, obesity & metabolism · 2021 · 62 citations · Sandeep Dhindsa
FIB-4 as a screening and disease monitoring method in pre-fibrotic stages of metabolic dysfunction-associated fatty liver disease (MASLD).
Journal of diabetes and its complications · 2024 · 26 citations · Stewart Albert
Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021 · 60 citations · Sandeep Dhindsa